Tuesday, November 5, 2019

Arcus Biosciences EPS misses by $0.06, beats on revenue

Arcus Biosciences (NYSE:RCUS): Q3 GAAP EPS of -$0.51 misses by $0.06.
Revenue of $1.75M (-59.2% Y/Y) beats by $0.21M.
Press Release
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.